SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Izzy who wrote (4245)5/6/1998 7:40:00 PM
From: Steve Fancy  Read Replies (2) | Respond to of 6136
 
Isaac, in case you haven't been following...Asia is falling apart, China hinting of devaluation, Hong Kong and Argentina could follow. Remember last fall? Logical or not, tends to take the entire market down big.

Of course my anxiety level is high...this is my business, and this one stung me big. Like to think I don't make the same mistake twice. For what it's worth I invest in some of the most volatile stocks that exist and have a very high tolerance level, but I try and stay on top of em. I still haven't found an answer yet as to what a typical delay is on releasing details of one phase when entering another, and am nervous about what they may reveal. I'm reasonably convinced the stock will be over 40 in a year, but not quite yet. It will be a very bad sign to me if monthly data in the next week or so has slipped below 30% with an increased sales force. We shall see. I don't find anything wrong with my concerns, and people that don't want to read 'em can just skip 'em. I though my suggestion today that the stock may actually be 45-50 in a year was positive. I don't know what other folks are expecting, but you can only reasonably expect so much IMO. Important factor in weighing risk/reward looking forward. IR, they're not going to tell me anything I don't know.

sf



To: Izzy who wrote (4245)5/6/1998 8:25:00 PM
From: Steve Fancy  Respond to of 6136
 
Isaac, I came back in from trying to beat the rain on yard work to clarify...I didn't fully answer your question. Seems to me the 52 week low was in the twenties...the stock had broken key support at 34 a couple of times...quite often stocks with no news tend to move with the market. We've had a couple of down days. If it hadn't been for the excitement, I can almost guarantee it wouldn't still have been at 33 1/2 to 34.

The thought of all the private email floating back and forth to try and shut me up really bugs me. I have to try and deal with facts and opinions, of which there are many if you look on this company. Like it or not, sentiment has not been on our side, and I have and still am trying to get to the bottom of it. As I told you, I'm making decisions in the next week or so as to whether I should bail from my AGPH positions at a huge loss that I think I've mentioned to you. My gut based on the excitement is to hold a little longer. But my gut also suggest that AGPH advanced cancer drugs may not measure up to others, and may be short lived. That coupled with the increased competition in the HIV market, may keep AGPH a medicore investment at best. Then again, someone may come in and buy 'em up at a huge premium.

I wish us all the best of luck...I really do. I won't pretend though.

sf